THE BENEFITS OF SEQUENCING ADJUVANT TAMOXIFEN AND ANASTROZOLE IN POSTMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER: 5 YEAR-ANALYSIS OF ABCSG TRIAL 8. SABCS 2005 ABSTRACT 13.